PharmaLundensis Investor Relations Material
Latest events
Q1 2025
15 May, 2025
Q4 2024
12 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PharmaLundensis
Access all reports
PharmaLundensis AB is a Sweden-based biotechnology company focused on developing treatments and solutions for respiratory diseases. The company specializes in research aimed at addressing chronic obstructive pulmonary disease (COPD) and related conditions. In addition to its pharmaceutical development activities, PharmaLundensis explores environmentally friendly methods for reducing medical waste and chemical emissions in healthcare. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
)
)
)